ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
7
views
0
references
Top references
cited by
2
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,671
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
ND2 COST-UTILITY ANALYSIS OF SINGLE DOSE GENE-REPLACEMENT THERAPY FOR SPINAL MUSCULAR ATROPHY TYPE 1 COMPARED TO CHRONIC NUSINERSEN TREATMENT
Author(s):
D. Malone
,
R. Dean
,
B. Miller
,
R. Arjunji
,
D.E. Feltner
,
D.M. Sproule
,
I.S. Jensen
,
B. Maru
,
O. Dabbous
Publication date
Created:
May 2019
Publication date
(Print):
May 2019
Journal:
Value in Health
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
Further versions
open (via crossref license)
Powered by
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Core Readings in Statistical Mediation Analysis
Author and article information
Journal
Title:
Value in Health
Abbreviated Title:
Value in Health
Publisher:
Elsevier BV
ISSN (Print):
10983015
Publication date Created:
May 2019
Publication date (Print):
May 2019
Volume
: 22
Pages
: S42-S43
Article
DOI:
10.1016/j.jval.2019.04.060
SO-VID:
b73769c8-835a-43bd-8305-a7cec3fa15b8
Copyright ©
© 2019
License:
https://www.elsevier.com/tdm/userlicense/1.0/
History
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,671
Expanded Access for Nusinersen in Patients With Spinal Muscular Atropy: Negotiating Limited Data, Limited Alternative Treatments, and Limited Hospital Resources.
Authors:
Holly Taylor
,
Benjamin S Wilfond
,
Christian Morales
PRO16 IMPROVED QUALITY OF LIFE FOR PATIENTS AND CAREGIVERS AMONG PATIENTS WITH LATER-ONSET SMA FOLLOWING TREATMENT WITH NUSINERSEN
Authors:
S. Zuluaga Sanchez
,
M Purser
,
G Mader
…
Spinal muscular atrophy: an integrated medical and pharmacy claims analysis of nusinersen uptake and gene therapy forecast among 15 million commercially insured
Authors:
C Starner
,
P Gleason
See all similar
Cited by
2
Systematic Literature Review to Assess Economic Evaluations in Spinal Muscular Atrophy (SMA)
Authors:
Noman Paracha
,
Pollyanna Hudson
,
Stephen Mitchell
…
Systematic Literature Review of Clinical and Economic Evidence for Spinal Muscular Atrophy
Authors:
Min Yang
,
Hiroyuki Awano
,
Satoru Tanaka
…
See all cited by